Regardless of these discrepancies, in all cases, AR promotes the activation of FGFR in prostate cancer cells, which results in phosphorylation of FRS2 and activation of the downstream Ras/Raf/MEK/ERK signaling pathway. The gene discussed is FRS2; the disease is Familial prostate cancer.